Have a personal or library account? Click to login
In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells Cover

In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells

Acta Pharmaceutica
Volume 72 (2022): Issue 4 (December 2022)
By: Marijana Šimić Jovičić,  Maja Pušić,  Maja Antunović,  Maja Ledinski,  Lucija Librenjak,  Robert Kolundžić,  Tomislav Ribičić,  Vladimir Trkulja and  Inga Urlić  
Open Access
|Oct 2022

Authors

Marijana Šimić Jovičić

Children’s Hospital Zagreb, Department of Pediatric Orthopedics, Zagreb, Croatia

Maja Pušić

Faculty of Science, University of Zagreb Department of Molecular Biology, Zagreb, Croatia

Maja Antunović

Faculty of Science, University of Zagreb Department of Molecular Biology, Zagreb, Croatia

Maja Ledinski

Faculty of Science, University of Zagreb Department of Molecular Biology, Zagreb, Croatia

Lucija Librenjak

Faculty of Science, University of Zagreb Department of Molecular Biology, Zagreb, Croatia

Robert Kolundžić

Department of Trauma Surgery University Hospital Centre “Sestre Milosrdnice”, Zagreb, Croatia

Tomislav Ribičić

Children’s Hospital Zagreb, Department of Pediatric Orthopedics, Zagreb, Croatia

Vladimir Trkulja

School of Medicine, University of Zagreb, Department of Pharmacology Zagreb, Croatia

Inga Urlić

inga.urlic@biol.pmf.hr

Faculty of Science, University of Zagreb Department of Molecular Biology, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2022-0040 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 599 - 613
Accepted on: Jul 19, 2022
Published on: Oct 18, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
osteosarcoma,
cancer stem cells,
tumor cell metabolism,
ascorbic acid
Related subjects:
Pharmacy,
Pharmacy, other

© 2022 Marijana Šimić Jovičić, Maja Pušić, Maja Antunović, Maja Ledinski, Lucija Librenjak, Robert Kolundžić, Tomislav Ribičić, Vladimir Trkulja, Inga Urlić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 72 (2022): Issue 4 (December 2022)Next article